Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of BIAsp 70/30 versus basal-bolus insulin therapy in type 1 diabetes
2010-019237-10Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Istituto Giannina Gaslini. Primary endpoint: Primary efficacy. Started Mar 2010; status: active.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2010-019237-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019237-10.